Ayala Pharmaceuticals (NASDAQ:ADXS) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a note issued to investors on Friday. The firm set a “sell” rating on the stock. Ayala Pharmaceuticals Price Performance Ayala Pharmaceuticals Company Profile (Get Rating) Advaxis, Inc is a biotechnology company, which engages in the discovery, development and commercialization of cancer […]